Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomere dysfunction in hypertension.

José J Fuster1, Javier Díez, Vicente Andrés

  • 1Laboratory of Vascular Biology, Department of Molecular and Cellular Pathology and Therapy, Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas, 46010 Valencia, Spain.

Journal of Hypertension
|October 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hematopoietic somatic mutations in atherosclerotic cardiovascular disease.

Atherosclerosis·2026
Same author

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

Cancers·2026
Same author

No Effect of <i>Ppm1d</i>-Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year period.

GeroScience·2026
Same author

AID and TET2 cooperate to demethylate Irf4 for plasma cell fate in germinal center B cells.

The Journal of experimental medicine·2026
Same author

Mitochondrial metabolism regulates the immunogenic responsiveness of dendritic cells.

Cell metabolism·2026
Same journal

Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.

Journal of hypertension·2026
Same journal

Erratum: Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter study.

Journal of hypertension·2026
Same journal

Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.

Journal of hypertension·2026
Same journal

Reply to comment: Limited public understanding of the risk factors and complications of hypertension.

Journal of hypertension·2026
Same journal

What magnesium depletion score can tell us about arterial stiffness.

Journal of hypertension·2026
Same journal

Nephron deficit as susceptibility, not determinism.

Journal of hypertension·2026
See all related articles

Aging accelerates hypertension risk, linked to telomere shortening. This review explores how telomere attrition may contribute to high blood pressure and organ damage, suggesting potential therapeutic targets.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Aging Research

Background:

  • Aging is a primary risk factor for hypertension and cardiovascular disease.
  • Telomeres, protective DNA caps, shorten with age, potentially causing genomic instability and cellular senescence.
  • Telomere shortening is implicated in organismal aging and age-related diseases.

Purpose of the Study:

  • To review animal and human studies on the link between telomere shortening and hypertension.
  • To explore the role of telomere attrition in the pathogenesis of hypertension and target organ damage.
  • To identify potential clinical applications of this emerging research.

Main Methods:

  • Review of existing animal and human studies.
  • Analysis of literature on telomere biology and hypertension.

Related Experiment Videos

  • Synthesis of evidence linking telomere dysfunction to cardiovascular health.

    • Main Results:

    • Evidence suggests a role for telomere shortening and altered telomerase activity in hypertension development.
    • Telomere dysfunction may contribute to hypertension-related target organ damage.
    • The precise molecular mechanisms connecting telomere dysfunction and hypertension require further investigation.

    Conclusions:

    • Telomere attrition is increasingly recognized as a factor in hypertension pathogenesis.
    • Further research is needed to elucidate the molecular links between telomere dysfunction and hypertension.
    • Understanding these connections may lead to novel clinical strategies for managing hypertension.